Pharma Mar (CHIX:PHME) Cyclically Adjusted Book per Share: €7.60 (As of Mar. 2026)


CHIX:PHME Pharma Mar SA CHIX:PHME
79 GF Score
Price €66.30
GF Value €82.06
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Pharma Mar Cyclically Adjusted Book per Share?

Pharma Mar CHIX:PHME 79 Cyclically Adjusted Book per Share is €7.60 as of Mar. 2026. GuruFocus rates CHIX:PHME with a GF Score™ of 79/100 and a GF Value™ of €82.06 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pharma Mar's adjusted book value per share for the three months ended in Mar. 2026 was €14.427. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €7.60 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pharma Mar's average Cyclically Adjusted Book Growth Rate was 13.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 15.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 21.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pharma Mar was 26.10% per year. The lowest was -12.10% per year. And the median was 15.90% per year.

As of today (2026-07-03), Pharma Mar's current stock price is €66.30. Pharma Mar's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €7.60. Pharma Mar's Cyclically Adjusted PB Ratio of today is 8.72.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharma Mar was 49.07. The lowest was 3.90. And the median was 11.05.


Pharma Mar  (CHIX:PHMe) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pharma Mar's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=66.30/7.60
=8.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharma Mar was 49.07. The lowest was 3.90. And the median was 11.05.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pharma Mar Cyclically Adjusted Book per Share Related Terms


Pharma Mar Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Pharma Mar's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Cyclically Adjusted Book per Share Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.63 4.98 4.56 5.62 7.29

Pharma Mar Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.27 7.18 6.87 7.29 7.60

CHIX:PHME vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Pharma Mar's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Cyclically Adjusted PB Ratio falls into.


CHIX:PHME
79GF Score
Pharma Mar SA CHIX:PHME
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Mar Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharma Mar's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=14.427/129.8600*129.8600
=14.427

Current CPI (Mar. 2026) = 129.8600.

Pharma Mar Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.389 100.333 4.386
201609 3.256 99.737 4.239
201612 2.843 101.842 3.625
201703 2.713 100.896 3.492
201706 2.558 101.848 3.262
201709 2.125 101.524 2.718
201712 1.457 102.975 1.837
201803 1.385 102.122 1.761
201806 1.628 104.165 2.030
201809 1.743 103.818 2.180
201812 1.159 104.193 1.445
201903 0.618 103.488 0.775
201906 0.007 104.612 0.009
201909 -0.287 103.905 -0.359
201912 0.615 105.015 0.761
202003 4.398 103.469 5.520
202006 5.847 104.254 7.283
202009 5.406 103.521 6.781
202012 5.671 104.456 7.050
202103 7.025 104.857 8.700
202106 7.430 107.102 9.009
202109 7.951 107.669 9.590
202112 9.878 111.298 11.525
202203 11.204 115.153 12.635
202206 11.438 118.044 12.583
202209 11.735 117.221 13.000
202212 12.313 117.650 13.591
202303 12.070 118.948 13.177
202306 11.698 120.278 12.630
202309 11.589 121.343 12.402
202312 10.966 121.300 11.740
202403 11.005 122.762 11.641
202406 10.342 124.409 10.795
202409 10.485 123.121 11.059
202412 11.855 124.753 12.340
202503 11.282 125.531 11.671
202506 11.561 127.251 11.798
202509 11.500 126.840 11.774
202512 14.507 128.400 14.672
202603 14.427 129.860 14.427

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €7.60 mean?
Pharma Mar (CHIX:PHME) has a Cyclically Adjusted Book per Share of €7.60 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pharma Mar and its competitors.
Is Pharma Mar's Cyclically Adjusted Book per Share too high?
Pharma Mar's current Cyclically Adjusted Book per Share is €7.60. Overall, Pharma Mar has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Pharma Mar's Cyclically Adjusted Book per Share of €7.60 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pharma Mar and its competitors. Pharma Mar's current Cyclically Adjusted Book per Share is €7.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Based on GuruFocus' analysis, Pharma Mar (CHIX:PHME) is currently considered Modestly Undervalued. The stock's GF Value™ is €82.06, compared to a current price of €66.30 — trading 19.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is €7.60. Pharma Mar's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Pharma Mar (CHIX:PHME), the current Cyclically Adjusted Book per Share is €7.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Mar (CHIX:PHME) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of €66.30 is trading 19.2% below its estimated GF Value™ of €82.06. GuruFocus considers Pharma Mar to be Modestly Undervalued.

Key valuation signals for CHIX:PHME:

  • Cyclically Adjusted Book per Share: €7.60
  • GF Value™: €82.06 vs. price of €66.30 (19.2% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the CHIX:PHME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
79GF Score

Get the complete analysis for CHIX:PHME

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€66.30
Price
€82.06
GF Value